Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

NCT00118040 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Recurrent Bladder Carcinoma
Stage I Bladder Cancer AJCC v6 and v7
Stage II Bladder Cancer AJCC v6 and v7
Stage III Bladder Cancer AJCC v6 and v7

Interventions

DRUG: Genistein
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
OTHER: Placebo Administration
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

National Cancer Institute (NCI)